AI and Healthcare

Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and real-world data integration are helping to overcome traditional challenges in bringing new therapies to patients faster. They also examine the potential for collaboration between AI technology and clinical expertise to drive future breakthroughs in medicine.

Tom Neyarapally, an expert in AI-driven drug discovery, shares insights on the groundbreaking role of AI in drug development. He discusses the importance of collaboration between pharmaceutical giants and startups to enhance personalized therapies. Neyarapally emphasizes overcoming data challenges for better patient experiences and the need for accessible datasets for effective AI applications. The conversation also covers economic hurdles in drug discovery and how innovative technologies could make medications more affordable.

Explore how AI is transforming drug discovery by enabling the rapid screening of billions of molecules and identifying new uses for existing drugs. This approach integrates patient data with advanced tools to predict effective treatments for diseases with unmet medical needs, significantly reducing the time and cost of development.

Dr. Debra Patt, a prominent breast oncologist and leader at Texas Oncology, shares her insights on the transformative role of AI in modern healthcare. She discusses how AI enhances cancer diagnostics, treatment decisions, and patient education. The conversation delves into AI's impact on drug discovery, improving clinical trial efficiency, and reducing costs. They also highlight the need for collaboration between clinicians and technology while addressing data integration challenges and ethical considerations in AI usage, emphasizing personalized patient care.

Dr. Sanjay Juneja and Dr. Debra Patt discuss patient data in healthcare, including de-identification, data aggregation for research, and the evolving role of AI. They explore how communication systems and real-world evidence improve care delivery, reduce ER visits, and enhance efficiency for healthcare providers.

Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.

An overview of ASCO's approach to artificial intelligence in cancer care, focusing on responsible use, transparency, and the importance of keeping physicians at the center of decision-making. The clip discusses guidelines, challenges like biases and model limitations, and how AI can complement personalized care.

Dr. Debra Patt and Dr. Sanjay Juneja explore how AI is reshaping healthcare, focusing on its impact on physicians and patient care. Discover how AI tools are seamlessly integrated into care delivery, from enhancing cancer diagnostics and automating clinical documentation to improving administrative efficiency. Learn about AI-powered scribe services that reduce doctors’ workloads, enabling real-time patient notes, better disease management, and enhanced communication with caregivers. Additionally, we explore AI's role in drug discovery, clinical trial optimization, and streamlining insurance approvals.

Discover how AI is reshaping the financial landscape of healthcare. Learn about innovative tools like ambient listening and real-time monitoring that enhance patient care. Explore the role of AI in educating patients to manage treatment side effects effectively. Delve into groundbreaking advancements in drug discovery and clinical trials, unlocking the potential for personalized therapies that improve outcomes and reduce toxicity. This enlightening discussion underscores the critical intersection of technology and health economics.

In this episode, Dr. Sanjay Juneja is joined by Mika Newton, CEO of xCures, to explore how AI is transforming the future of medicine. Together, they discuss tackling critical challenges like resource shortages, improving patient triaging, and leveraging data for smarter, faster decision-making. Mika shares his unique insights on how technology is reshaping healthcare systems and the exciting opportunities ahead. Don’t miss this engaging conversation —and stay tuned for a surprising reveal at the end!